Soliris (2014-06-06) Jun 6, 2014 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type II
Lot or serial number Companies Brand name Dosage form DIN, NPN, DIN-HIM Strength 00015A Recalling Firm Alexion Pharma Canada Corp 400 Applewood Crescent, Suite 120 Vaughan Ontario CANADA Marketing Authorization Holder Alexion Pharma International, SARL 34 Avenue du Tribunal Federal Soliris Solution DIN 02322285 Eculizumab - 10 mg/ml
Recalled Products
Soliris
Due to the presence of visible particles in a limited number of vials from a lot of Soliris which was distributed in another market. Lots which were manufactured using the same process are being recalled.
Hospitals/Pharmacies across Canada